Tan, Alice J.Streicher, Jenna L.Merola, Joseph F.Noe, Megan H.2023-06-142023-06-142021-09-09Tan AJ, Streicher JL, Merola JF, Noe MH. Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review. Dermatol Online J. 2021;27(9):10.5070/D327955114. Published 2021 Sep 9. doi:10.5070/D327955114https://hdl.handle.net/1805/33742Adults with chronic inflammatory skin disease are at increased risk of vaccine-preventable illnesses and infections, likely because of the underlying disease itself and also their treatment with immunosuppressive and immunomodulatory medications. Despite the association between these agents and increased susceptibility to infection, vaccination rates in dermatology patients remain low. Although preventative care such as vaccinations is typically managed by primary care providers, dermatologists serve a critical role in spreading awareness of the specific risks of immunosuppressive and immunomodulatory agents and promoting understanding of individualized vaccine recommendations. In this review, we provide evidence-based information on vaccine recommendations for adult dermatology patients, specific to age and medication use.en-USPublisher PolicyGeneral dermatologyImmunosuppressionMedicalPreventative careVaccinationVaccineArticle